High-cost drugs set for price cuts

Nicholas O’Donoghue 08/01/2026

Pharmacy owners urged to monitor stocks of two medicines that are among the top 50 PBS brands by highest cost to the government, ahead of price changes on 1 February 2026 The Pharmacy Guild of Australia is planning to engage with manufacturers in an effort to cushion the cost of cuts to the Pharmaceutical Benefits Scheme (PBS) prices of aflibercept (Eylea) and cladribine

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

High-cost drugs set for price cuts

Previous 14.5 million PBS scripts in RACFs

Next Cocaine in hayfever

MENU

ajp.com.au

Previous 14.5 million PBS scripts in RACFs

Next Cocaine in hayfever

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.